Fluorourasil: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
JohnThorne (bicara | kontrib) k menambahkan Kategori:Keton menggunakan HotCat |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
(13 revisi perantara oleh 7 pengguna tidak ditampilkan) | |||
Baris 1:
{{Drugbox
| verifiedrevid = 443823794
| IUPAC_name = 5-fluoro-1''H''-
| image = Fluorouracil.svg
| width = 120
Baris 11:
| MedlinePlus = a682708
| pregnancy_AU = D
| pregnancy_category = <br>D (
| legal_US = hanya Rx
| routes_of_administration = [[
<!--Pharmacokinetic data-->
| bioavailability = 28
| protein_bound = 8
| metabolism = Intraselular dan [[hati|
| elimination_half-life = 10
| excretion = [[
<!--Identifiers-->
Baris 53:
| melting_point = 282 - 283
}}
'''
<!--
== Uses ==
Baris 107:
[http://fightcolorectalcancer.org/research_news/2008/07/switching_from_5fu_to_xeloda_can_cause_significant_side_effects "Switching from 5FU to Xeloda Can Cause Significant Side Effects"]</ref>
Trissel and colleagues have shown that 5-FU and leucovorin are physically incompatible when mixed in portable-pump reservoirs.
== History ==
Baris 115:
{{FluoropyrimidineActivity WP1601}}
-->
== Referensi ==
{{reflist}}
== Pranala luar ==
* {{en}} [http://www.cancerbackup.org.uk/Treatments/Chemotherapy/Individualdrugs/Fluorouracil Cancerbackup.org.uk
<!--
{{Chemotherapeutic agents}}
Baris 129 ⟶ 130:
-->
[[Kategori:
[[Kategori:
[[Kategori:
[[Kategori:Penghambat sintase timidilat]]
[[Kategori:Turunan urasil]]
[[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]
[[Kategori:Basa nukleotida]]
|